Lista de obras -

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

artículo científico publicado en 2018

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

artículo científico publicado en 2007

Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features

artículo científico publicado en 2017

Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study.

artículo científico publicado en 2017

Bipolar II disorder in patients with a current diagnosis of recurrent depression

artículo científico publicado en 2014

Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study

scientific article published on 21 September 2020

Daily dynamics of time perception in bipolar II disorder patients with redarted or anxious depression

artículo científico publicado en 2016

Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study

artículo científico publicado en 2020

Design and validation of standardized clinical and functional remission criteria in schizophrenia.

scientific article published on 28 January 2014

EEG spectral characteristics in resistant depression patients on transcranial magnetic stimulation treatment

artículo científico publicado en 2015

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

artículo científico publicado en 2010

Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.

artículo científico publicado en 2009

Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-Mix study.

artículo científico publicado en 2018

Management of schizophrenia: clinical experience with asenapine.

artículo científico

Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study.

artículo científico publicado en 2015

Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study

artículo científico publicado en 2017

Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis

scientific article published on 18 June 2019

Psychiatry in selected countries of Central and Eastern Europe: an overview of the current situation.

artículo científico publicado en 2006

Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts

scientific article published on 04 June 2019

Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population ⬇️

artículo científico publicado el 5 de enero de 2012

Suicide attempts in major depressive episode: evidence from the BRIDGE-II-Mix study.

artículo científico publicado en 2015

Sultans of Swing: A Reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a Post Hoc Analysis of the BRIDGE-II-MIX Study

artículo científico publicado en 2019

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

artículo científico publicado en 2019

The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study

scientific article published on 25 December 2018

The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state?

artículo científico publicado en 2019

Towards a framework for treatment effectiveness in schizophrenia.

artículo científico publicado en 2014

Validation of the Russian version of Stress and Anxiety to Viral Epidemics – 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic

artículo científico publicado en 2022

Validation of the Russian version of the Hypomania Checklist (HCL-32) for the detection of Bipolar II disorder in patients with a current diagnosis of recurrent depression

artículo científico publicado en 2013

[A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]

artículo científico publicado en 2015

[Problems of mental health in the situation of COVID-19 pandemic]

artículo científico publicado en 2020

Lista de obras de

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features

Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study.

Bipolar II disorder in patients with a current diagnosis of recurrent depression

Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study

Daily dynamics of time perception in bipolar II disorder patients with redarted or anxious depression

Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study

Design and validation of standardized clinical and functional remission criteria in schizophrenia.

EEG spectral characteristics in resistant depression patients on transcranial magnetic stimulation treatment

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.

Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-Mix study.

Management of schizophrenia: clinical experience with asenapine.

Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study.

Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study

Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis

Psychiatry in selected countries of Central and Eastern Europe: an overview of the current situation.

Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts

Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population ⬇️

Suicide attempts in major depressive episode: evidence from the BRIDGE-II-Mix study.

Sultans of Swing: A Reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a Post Hoc Analysis of the BRIDGE-II-MIX Study

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study

The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state?

Towards a framework for treatment effectiveness in schizophrenia.

Validation of the Russian version of Stress and Anxiety to Viral Epidemics – 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic

Validation of the Russian version of the Hypomania Checklist (HCL-32) for the detection of Bipolar II disorder in patients with a current diagnosis of recurrent depression

[A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]

[Problems of mental health in the situation of COVID-19 pandemic]

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder